Literature DB >> 19816655

Concordance between severity of disease, disability and health-related quality of life in myasthenia gravis.

Alberto Raggi1, Matilde Leonardi, Carlo Antozzi, Paolo Confalonieri, Lorenzo Maggi, Ferdinando Cornelio, Renato Mantegazza.   

Abstract

Aim of this study is to verify whether there is concordance between disease's severity, health-related quality of life (HRQoL) and disability in patients with myasthenia gravis (MG). 102 MG patients were clustered on the basis of HRQoL and disability scores into three groups: low disability and low HRQoL decrement (51 patients), intermediate disability and HRQoL decrement (28 patients), severe disability and high HRQoL decrement (23 patients). Cross tabulation with symmetric measures (Cramer's V and Contingency Coefficient) was used to verify the relationships between disease severity groups, based on the Myasthenia Gravis Foundation of America (MGFA) criteria, and obtained clusters. Results confirm a significant relationship between MG severity groups, HRQoL and disability profiles. In our opinion, HRQoL and disability instruments should be employed in clinical trials to match efficacy of treatments, measured on symptoms' reductions only, with their effects on patients' disability and HRQoL.

Entities:  

Mesh:

Year:  2009        PMID: 19816655     DOI: 10.1007/s10072-009-0167-y

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  24 in total

1.  Quality of life and well-being of patients with myasthenia gravis.

Authors:  R H Paul; J M Nash; R A Cohen; J M Gilchrist; J M Goldstein
Journal:  Muscle Nerve       Date:  2001-04       Impact factor: 3.217

2.  Myasthenia gravis activities of daily living profile.

Authors:  G I Wolfe; L Herbelin; S P Nations; B Foster; W W Bryan; R J Barohn
Journal:  Neurology       Date:  1999-04-22       Impact factor: 9.910

3.  Validity and reliability of two muscle strength scores commonly used as endpoints in assessing treatment of myasthenia gravis.

Authors:  T Sharshar; S Chevret; M Mazighi; P Chillet; G Huberfeld; C Berreotta; M Houfani; P Gajdos
Journal:  J Neurol       Date:  2000-04       Impact factor: 4.849

4.  Quantitative myasthenia gravis score: assessment of responsiveness and longitudinal validity.

Authors:  R S Bedlack; D L Simel; H Bosworth; G Samsa; B Tucker-Lipscomb; D B Sanders
Journal:  Neurology       Date:  2005-06-14       Impact factor: 9.910

5.  Self-reported Pain Affects Quality of Life in Myasthenia Gravis.

Authors:  Kevin R Scott; Milind J Kothari
Journal:  J Clin Neuromuscul Dis       Date:  2006-03

6.  Health-related quality of life in patients with myasthenia gravis and the relationship between patient-oriented assessment and conventional measurements.

Authors:  L Padua; A Evoli; I Aprile; P Caliandro; S Mazza; R Padua; P Tonali
Journal:  Neurol Sci       Date:  2001-10       Impact factor: 3.307

7.  ACTIVLIM: a Rasch-built measure of activity limitations in children and adults with neuromuscular disorders.

Authors:  Laure Vandervelde; Peter Y K Van den Bergh; Nathalie Goemans; Jean-Louis Thonnard
Journal:  Neuromuscul Disord       Date:  2007-04-11       Impact factor: 4.296

8.  Disease-specific measure of quality of life for myasthenia gravis.

Authors:  Larry L Mullins; Melissa Y Carpentier; Robert H Paul; Donald B Sanders
Journal:  Muscle Nerve       Date:  2008-08       Impact factor: 3.217

9.  Correlation between regional myasthenic weakness and mental aspects of quality of life.

Authors:  A Rostedt; L Padua; E V Stålberg
Journal:  Eur J Neurol       Date:  2006-02       Impact factor: 6.089

10.  An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis.

Authors:  D B Sanders; I K Hart; R Mantegazza; S S Shukla; Z A Siddiqi; M H V De Baets; A Melms; M W Nicolle; N Solomons; D P Richman
Journal:  Neurology       Date:  2008-04-23       Impact factor: 9.910

View more
  14 in total

1.  Concordance between severity of disease, prevalence of nonmotor symptoms, patient-reported quality of life and disability and use of medication in Parkinson's disease.

Authors:  Alberto Raggi; Matilde Leonardi; Venusia Covelli; Alberto Albanese; Paola Soliveri; Francesco Carella; Luigi Romito
Journal:  Neurol Sci       Date:  2011-11-10       Impact factor: 3.307

2.  Quality of life and life circumstances in German myasthenia gravis patients.

Authors:  Sabine Twork; Susanne Wiesmeth; Jörg Klewer; Dieter Pöhlau; Joachim Kugler
Journal:  Health Qual Life Outcomes       Date:  2010-11-11       Impact factor: 3.186

3.  Health-related quality of life in ALS, myasthenia gravis and facioscapulohumeral muscular dystrophy.

Authors:  Yaroslav Winter; Karsten Schepelmann; Annika E Spottke; Detlef Claus; Christoph Grothe; Rolf Schröder; Dieter Heuss; Stefan Vielhaber; Björn Tackenberg; Veit Mylius; Jens-Peter Reese; Reinhard Kiefer; Bertold Schrank; Wolfgang H Oertel; Richard Dodel
Journal:  J Neurol       Date:  2010-04-10       Impact factor: 4.849

4.  Value and utility of disease-specific and generic instruments for assessing disability in patients with migraine, and their relationships with health-related quality of life.

Authors:  Alberto Raggi; Matilde Leonardi; Gennaro Bussone; Domenico D'Amico
Journal:  Neurol Sci       Date:  2010-12-14       Impact factor: 3.307

5.  Assessment of health-related quality of life in patients with myasthenia gravis in Belgrade (Serbia).

Authors:  Ivana Z Basta; Tatjana D Pekmezović; Stojan Z Perić; Darija B Kisić-Tepavčević; Vidosava M Rakočević-Stojanović; Zorica D Stević; Dragana V Lavrnić
Journal:  Neurol Sci       Date:  2012-08-09       Impact factor: 3.307

6.  Social support and self-efficacy in patients with Myasthenia Gravis: a common pathway towards positive health outcomes.

Authors:  Alberto Raggi; Matilde Leonardi; Renato Mantegazza; Silvia Casale; Giulia Fioravanti
Journal:  Neurol Sci       Date:  2010-04       Impact factor: 3.307

7.  Validation of the MG-DIS: a disability assessment for myasthenia gravis.

Authors:  Alberto Raggi; Matilde Leonardi; Silvia Schiavolin; Carlo Antozzi; Greta Brenna; Lorenzo Maggi; Renato Mantegazza
Journal:  J Neurol       Date:  2016-03-01       Impact factor: 4.849

8.  Major motor-functional determinants associated with poor self-reported health-related quality of life in myasthenia gravis patients.

Authors:  David Cioncoloni; Stefania Casali; Federica Ginanneschi; Marisa Carone; Boni Veronica; Alessandro Rossi; Fabio Giannini
Journal:  Neurol Sci       Date:  2016-04-01       Impact factor: 3.307

9.  Factors associated with quality of life of people with Myasthenia Gravis.

Authors:  Ansuk Jeong; Ju-Hong Min; Yu Kyoung Kang; Juhyeon Kim; Misong Choi; Jin Myoung Seok; Byung Joon Kim
Journal:  PLoS One       Date:  2018-11-08       Impact factor: 3.240

10.  An up-date on health-related quality of life in myasthenia gravis -results from population based cohorts.

Authors:  M I Boldingh; L Dekker; A H Maniaol; C Brunborg; A F Lipka; E H Niks; J J G M Verschuuren; C M E Tallaksen
Journal:  Health Qual Life Outcomes       Date:  2015-08-01       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.